Sarcoidosis, Cardiac (DBCOND0148063)

Identifiers

Synonyms

Cardiac Sarcoidosis / Cardiac sarcoidosis (disorder) / Sarcoidosis cordis / Heart sarcoid disease

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT03103490	18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation	Florilglutamic acid F-18	diagnostic	2	terminated
NCT03057002	UTSW HP [13-C] Pyruvate Injection in HCM	No drug interventions	Not Available	Not Available	recruiting
NCT03705884	PET/MR Imaging In Patients With Cardiac Sarcoidosis	Prednisolone	diagnostic	Not Available	completed
NCT01210677	Cardiac Sarcoidosis Response To Steroids Trial	Prednisone	treatment	4	withdrawn
NCT03746847	PET Imaging in Patients With Suspected Cardiac Sarcoidosis	Dotatate	Not Available	Not Available	completed
NCT03549598	d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis	Dotatate gallium Ga-68	diagnostic	4	completed
NCT05793398	Biomaterial Collection - and Analysis in Cardiac Sarcoidosis	No drug interventions	Not Available	Not Available	not_yet_recruiting
NCT03593759	Cardiac Sarcoidosis Randomized Trial	Methotrexate Prednisolone Prednisone	treatment	3	recruiting
NCT01477359	Cardiac Sarcoidosis Multi-Center Prospective Cohort	No drug interventions	Not Available	Not Available	recruiting
NCT04774549	Inflammatory Cardiomyopathy Bern Registry	No drug interventions	Not Available	Not Available	enrolling_by_invitation
NCT03923049	Feasibility and Accuracy of Hybrid Magnetic Resonance and Positron Emission Tomography With 18F-Fluorodeoxyglucose in Diagnosing Cardiac Sarcoidosis	No drug interventions	diagnostic	Not Available	terminated
NCT04737317	Diagnostic Criteria in Cardiac Sarcoidosis	No drug interventions	Not Available	Not Available	recruiting
NCT04206163	Somatostatin Receptor Imaging in Acute Myocarditis and Cardiac Sarcoidosis	No drug interventions	diagnostic	Not Available	recruiting
NCT01729169	Cardiac Sarcoidosis: FDG PET vs. Ga-DOTANOC PET	No drug interventions	Not Available	Not Available	completed
NCT04758650	Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis	No drug interventions	diagnostic	2	recruiting
NCT03902223	Routine Cardiac Screening in Sarcoidosis Patients	No drug interventions	screening	Not Available	recruiting
NCT03049254	Mayo AVC Registry and Biobank	No drug interventions	Not Available	Not Available	recruiting
NCT05954507	Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis	No drug interventions	diagnostic	Not Available	not_yet_recruiting
NCT06409585	Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition	No drug interventions	Not Available	Not Available	recruiting
NCT05499637	[68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation	Boclatixafortide gallium Ga-68	diagnostic	2	recruiting
NCT02812849	Somatostatin Receptor Imaging in Cardiac Sarcoidosis	Dotatate	Not Available	Not Available	withdrawn
NCT04017936	Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis	Anakinra	treatment	2	completed
NCT02017522	Non-Invasive Characterization in Cardiac Sarcoidosis	No drug interventions	basic_science	Not Available	terminated
NCT06510894	Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression	Sotagliflozin	Not Available	Not Available	not_yet_recruiting
NCT01764191	18F-FDG PET Imaging in Cardiac Sarcoidosis	No drug interventions	Not Available	Not Available	approved_for_marketing
NCT06131112	Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac Sarcoidosis	No drug interventions	Not Available	Not Available	recruiting
NCT03599414	CASPA: CArdiac Sarcoidosis in PApworth	No drug interventions	Not Available	Not Available	completed
NCT05145023	Development and Validation of a Health-related Quality of Life Tool for Patients With Cardiac Sarcoidosis	No drug interventions	Not Available	Not Available	recruiting
NCT05351554	A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarcoidosis	Namilumab Prednisone	treatment	2	terminated